Indole Hydrazide Compound IHZ-1 Induces Apoptosis and Autophagy via Activation of ROS/JNK Pathway in Hepatocellular Carcinoma

Manting Sun,Dan Liu,Yang Yuan,Juhua Dan,Shuting Jia,Ying Luo,Jing Liu
DOI: https://doi.org/10.3389/fonc.2022.811747
IF: 4.7
2022-02-07
Frontiers in Oncology
Abstract:Hepatocellular carcinoma is one of the most common primary malignant tumors of the digestive system. Compound 5-chloro- N ′-(2,4-dimethoxybenzylidene)-1 H -indole-2-carbohydrazide (IHZ-1/ZJQ-24) is a novel indole hydrazide derivative. In a recent study, we demonstrated that IHZ-1 inhibits tumor growth and induces cell apoptosis through inhibiting the kinase activity of mTORC1 without activation of AKT, which is associated with JNK/IRS-1 activation. However, the impact and mechanisms of JNK activation by IHZ-1 in hepatocellular carcinoma remains entirely unknown. Here, we find that IHZ-1 increases the generation of intracellular ROS and enhances autophagy. The phosphorylation of JNK induced by IHZ-1 was reversed by the decreased ROS level. Moreover, inhibition of ROS/JNK or autophagy equally attenuated apoptotic effect induced by IHZ-1. Our findings suggest that the activation of JNK by IHZ-1 treatment is dependent on the generation of ROS that mediates apoptosis and autophagy in hepatocellular carcinoma.
oncology
What problem does this paper attempt to address?